741252-19-7Relevant articles and documents
Design and synthesis of novel furan, furo[2,3-d]pyrimidine and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as potential VEGFR-2 inhibitors
Abd El-Mageed, Menna M.A.,Eissa, Amal A.M.,Farag, Awatef El-Said,Osman, Essam Eldin A.
, (2021)
Novel furan 6a-c, furo[2,3-d]pyrimidine 7a-f, 9, 10a-f, 12a,b, 14a-d and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine 8a-f derivatives were designed based on their structural similarity to a previously described oxazole VEGFR-2 back pocket binding fragment. The designed compounds were synthesized and screened for their in vitro VEGFR-2 inhibitory activity where they exhibited good to moderate nanomolar inhibition with improved ligand efficiencies. 8b and 10c (IC50 = 38.72 ± 1.7 and 41.40 ± 1.8 nM, respectively) were equipotent to sorafenib and 6a, 6c, 7f, 8a, 8c, 10b, 10f, 12b, 14c and 14d showed good activity (IC50 = 43.31–98.31 nM). The furotriazolopyrimidines 8a-c and furopyrimidine derivative 10c were further evaluated for their in vitro antiproliferative activity against human umbilical vein endothelial cells (HUVECs) where 8b showed higher potency than sorafenib and resulted in cell cycle arrest at G2/M phase whereas 8c revealed good antiproliferative activity with cell cycle arrest at G1 phase. Moreover, 8a-c and 10c showed significant inhibitory effects on the invasion and migration of HUVECs. Molecular docking study was conducted to gain insight about the potential binding mode. The furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives 8b and 8c represent interesting starting point for antiangiogenic compounds based on their activity and favorable drug likeness profiles.
A new chitosan biopolymer derivative as metal-complexing agent: Synthesis, characterization, and metal(II) ion adsorption studies
Krishnapriya,Kandaswamy
, p. 2013 - 2022 (2010)
In this study, a new chitosan biopolymer derivative (CTSL) has been synthesized by anchoring a new vanillin-based complexing agent or ligand, namely 4-hydroxy-3-methoxy-5-[(4-methylpiperazin-1-yl)methyl] benzaldehyde, (L) with chitosan (CTS) by means of condensation. The new material was characterized by elemental (CHN), spectral (FTIR and solid state 13C NMR), thermal (TG-DTA and DSC), structural (powder XRD), and morphological (SEM) analyses. The CTSL was employed to study the equilibrium adsorption of various metal ions, namely, Mn(II), Fe(II), Co(II), Cu(II), Ni(II), Cd(II), and Pb(II), as functions of pH of the solutions. Its kinetics of adsorption was evaluated utilizing the pseudo first order and pseudo second order equation models and the equilibrium data were analyzed by Langmuir isotherm model. The CTSL shows good adsorption capacity for metal ions studied in the order Cu(II) > Ni(II) > Cd(II) ≥ Co ≥ Mn(II) > Fe(II) > Pb(II) in all studied pH ranges due to the presence of many coordinating moieties present in it.
Design and synthesis of some barbituric and 1,3-dimethylbarbituric acid derivatives: A non-classical scaffold for potential PARP1 inhibitors
Eldin A. Osman, Essam,Hanafy, Noura S.,George, Riham F.,El-Moghazy, Samir M.
, (2020/09/16)
Six series based on barbituric acid 5a-e, 10a-d; thiobarbituric acid 6a-e, 11a-d and 1,3-dimethylbarbituric acid 7a-e, 12a-d were prepared and screened for their in vitro PARP1 inhibition. They revealed promising inhibition at nanomolar level especially compounds 5c, 7b, 7d and 7e (IC50 = 30.51, 41.60, 41.53 and 36.33 nM) with higher potency than olaparib (IC50 = 43.59 nM). Moreover, compounds 5b, 5d, 7a, 12a and 12c exhibited good comparable activity (IC50 = 65.93, 58.90, 66.57, 45.40 and 50.62 nM, respectively). Furthermore, the most active compounds 5c, 7b, 7d, 7e, 12a and 12c against PARP1 in vitro were evaluated in the BRCA1 mutated triple negative breast cancer cell line MDA-MB-436 where 5c and 12c showed higher potency compared to olaparib and result in cell cycle arrest at G2/M phase. 5c and 12c showed apoptotic effects in MDA-MB-436 and potentiated the cytotoxicity of temozolomide in A549 human lung epithelial cancer cell line. Compounds 5c and 12c represent interesting starting points towards PARP1 inhibitors.
Metal complexes with nitronyl nitroxide substituted phenolate ligands providing new magnetic exchange interaction pathways - Synthesis, structures, magnetic dilution studies, and Ab initio calculations
Schatzschneider, Ulrich,Weyhermueller, Thomas,Rentschler, Eva
, p. 2569 - 2586 (2007/10/03)
The synthesis and magnetic properties of seven new nitronyl nitroxide substituted phenolates with chelating amine groups are reported. Copper(II) and nickel(II) complexes prepared with these ligands are structurally and magnetically characterized, showing
